Wu Xiao-Yu, Zhuang Yao-Kun, Cai Yong, Dong Xiao-Qiao, Wang Ke-Yi, Du Quan, Yu Wen-Hua
The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
Department of Neurosurgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
J Int Med Res. 2021 Apr;49(4):3000605211009689. doi: 10.1177/03000605211009689.
The serum glucose/potassium ratio (GPR) is a potential prognostic predictor for acute brain injury-related diseases. We calculated the serum GPR in patients with acute intracerebral hemorrhage (ICH) and explored its prognostic value for long-term prognoses and ICH severity.
This retrospective cohort study consecutively included 92 patients with ICH and 92 healthy controls. The National Institutes of Health Stroke Scale (NIHSS) score, Glasgow coma scale (GCS) score, and hematoma volume were used to assess severity. A modified Rankin Scale score > 2 at 90 days post-stroke was defined as a poor outcome.
The serum GPR was significantly higher in patients than controls. The serum GPR was weakly correlated with the NIHSS score, GCS score, and hematoma volume. The serum GPR, GCS score, and hematoma volume were independently associated with poor outcomes. In the receiver operating characteristic curve analysis, the serum GPR remarkably discriminated patients at risk of poor outcomes at 90 days. The serum GPR significantly improved the prognostic predictive capability of hematoma volume and tended to increase that of the GCS score.
Serum GPR is an easily obtained clinical variable for predicting clinical outcomes after ICH.
血清葡萄糖/钾比值(GPR)是急性脑损伤相关疾病潜在的预后预测指标。我们计算了急性脑出血(ICH)患者的血清GPR,并探讨其对长期预后及ICH严重程度的预后价值。
这项回顾性队列研究连续纳入了92例ICH患者和92例健康对照。采用美国国立卫生研究院卒中量表(NIHSS)评分、格拉斯哥昏迷量表(GCS)评分及血肿体积评估严重程度。卒中后90天时改良Rankin量表评分>2定义为预后不良。
患者血清GPR显著高于对照组。血清GPR与NIHSS评分、GCS评分及血肿体积呈弱相关。血清GPR、GCS评分及血肿体积与预后不良独立相关。在受试者工作特征曲线分析中,血清GPR能显著区分90天时预后不良风险的患者。血清GPR显著提高了血肿体积的预后预测能力,并倾向于提高GCS评分的预后预测能力。
血清GPR是预测ICH后临床结局易于获取的临床变量。